WallStreetZen

NYSE: ABBV
AbbVie Inc Stock Forecast, Predictions & Price Target

Analyst price target for ABBV

Based on 9 analysts offering 12 month price targets for AbbVie Inc.
Min Forecast
$93.00-13.52%
Avg Forecast
$116.89+8.69%
Max Forecast
$144.00+33.9%

Should I buy or sell ABBV stock?

Strong Buy
Strong Buy
5 analysts 55.56%
Buy
4 analysts 44.44%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

ABBV stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
David Risinger
Morgan Stanley
Strong BuyMaintains$116.00+7.87%2021-01-28
Andrew Baum
Citigroup
Strong BuyMaintains$105.00-2.36%2020-09-02
Steve Chesney
Atlantic Equities
Strong BuyUpgrades$115.00+6.94%2020-06-23
David Toung
Argus Research
Strong BuyUpgrades$115.00+6.94%2020-06-02
Navin Jacob
UBS
Strong BuyMaintains$96.00-10.73%2020-04-13
Anonymous
SVB Leerink
BuyMaintains$144.00+33.90%2021-03-30
Geoff Porges
SVB Leerink
BuyMaintains$140.00+30.18%2021-02-04
Geoffrey Porges
SVB Leerink
BuyMaintains$128.00+19.03%2020-12-16
Randall Stanicky
RBC Capital
BuyUpgrades$93.00-13.52%2020-04-20

1 of 1

Forecast return on equity

Is ABBV forecast to generate an efficient return?
Company
167.22%
Industry
76.5%
Market
32,279.67%
ABBV's Return on Equity is forecast to be high in 3 years (167.22%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is ABBV forecast to generate an efficient return on assets?
Company
14.52%
Industry
16.91%
Market
11,627.87%
ABBV is forecast to generate lower Return on Assets (14.52%) than the US Drug Manufacturers - General industry average (16.91%)
Forecast

ABBV earnings per share forecast

What is ABBV's earnings per share in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
$12.50+357.88%
Avg 2 year Forecast
$13.92+409.89%
Avg 3 year Forecast
$12.06+341.76%
ABBV's earnings are forecast to grow at an exceptional rate of 67.34% per year
Forecast

ABBV revenue forecast

What is ABBV's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$55.8B+21.9%
Avg 2 year Forecast
$59.7B+30.31%
Avg 3 year Forecast
$56.2B+22.8%
ABBV's revenue is forecast to grow at a rate of 7.85% per year, which is not exceptional
Forecast

ABBV earnings growth forecast

How is ABBV forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
67.34%
Industry
34.05%
Market
23.11%
ABBV's earnings are forecast to grow faster (67.34% per year) than the US Drug Manufacturers - General industry average (34.05%)
Forecast
ABBV's earnings are forecast to grow faster (67.34% per year) than the US market average (23.11%)
Forecast
ABBV's earnings are forecast to grow faster (67.34% per year) than the risk-free savings rate (1.7%)
Forecast

ABBV revenue growth forecast

How is ABBV forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
7.85%
Industry
5.94%
Market
15.02%
ABBV's revenues are forecast to grow faster (7.85% per year) than the US Drug Manufacturers - General industry average (5.94%)
Forecast
ABBV's revenues are forecast to grow slower (7.85% per year) than the US market average (15.02%)
Forecast

AbbVie Stock Forecast FAQ

Is AbbVie Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NYSE: ABBV) stock is to Strong Buy ABBV stock.

Out of 9 analysts, 5 (55.56%) are recommending ABBV as a Strong Buy, 4 (44.44%) are recommending ABBV as a Buy, 0 (0%) are recommending ABBV as a Hold, 0 (0%) are recommending ABBV as a Sell, and 0 (0%) are recommending ABBV as a Strong Sell.

What is ABBV's earnings growth forecast for 2021-2023?

(NYSE: ABBV) AbbVie's forecast annual earnings growth rate of 67.34% is forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 34.05%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 23.11%.

AbbVie's earnings in 2021 is $4,616,000,000.On average, 8 Wall Street analysts forecast ABBV's earnings for 2021 to be $22,068,424,038, with the lowest ABBV earnings forecast at $21,803,602,949, and the highest ABBV earnings forecast at $22,509,792,518. On average, 7 Wall Street analysts forecast ABBV's earnings for 2022 to be $24,575,397,008, with the lowest ABBV earnings forecast at $23,392,529,480, and the highest ABBV earnings forecast at $25,864,192,972.

In 2023, ABBV is forecast to generate $21,291,615,511 in earnings, with the lowest earnings forecast at $19,755,653,198 and the highest earnings forecast at $22,615,720,954.

What is ABBV's revenue growth forecast for 2021-2023?

(NYSE: ABBV) AbbVie's forecast annual revenue growth rate of 7.85% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 5.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.02%.

AbbVie's revenue in 2021 is $45,804,000,000.On average, 5 Wall Street analysts forecast ABBV's revenue for 2021 to be $98,573,372,150,242, with the lowest ABBV revenue forecast at $98,213,314,336,490, and the highest ABBV revenue forecast at $99,482,690,087,127. On average, 5 Wall Street analysts forecast ABBV's revenue for 2022 to be $105,374,976,959,879, with the lowest ABBV revenue forecast at $103,352,608,926,343, and the highest ABBV revenue forecast at $107,623,290,346,080.

In 2023, ABBV is forecast to generate $99,304,115,930,763 in revenue, with the lowest revenue forecast at $96,940,407,638,007 and the highest revenue forecast at $101,691,297,964,800.

What is ABBV's forecast return on assets (ROA) for 2021-2024?

(NYSE: ABBV) forecast ROA is 14.52%, which is lower than the forecast US Drug Manufacturers - General industry average of 16.91%.

What is ABBV's Price Target?

According to 9 Wall Street analysts that have issued a 1 year ABBV price target, the average ABBV price target is $116.89, with the highest ABBV stock price forecast at $144.00 and the lowest ABBV stock price forecast at $93.00.

On average, Wall Street analysts predict that AbbVie's share price could stay at $116.89 by Mar 30, 2022. The average AbbVie stock price prediction forecasts a potential downside of N/A from the current ABBV share price of $107.54.

What is ABBV's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: ABBV) AbbVie's current Earnings Per Share (EPS) is $2.73. On average, analysts forecast that ABBV's EPS will be $12.50 for 2021, with the lowest EPS forecast at $12.35, and the highest EPS forecast at $12.75. On average, analysts forecast that ABBV's EPS will be $13.92 for 2022, with the lowest EPS forecast at $13.25, and the highest EPS forecast at $14.65. In 2023, ABBV's EPS is forecast to hit $12.06 (min: $11.19, max: $12.81).

What is ABBV's forecast return on equity (ROE) for 2021-2024?

(NYSE: ABBV) forecast ROE is 167.22%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.